Michael Thomas Miller, the Executive VP & CFO of $IBP, bought 1 shares of the company on 06-11-2026 for an estimated $200. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 0.0%. Following this trade, they now own 33,722 shares of this class of $IBP stock.
$IBP Insider Trading Activity
$IBP insiders have traded $IBP stock on the open market 12 times in the past 6 months. Of those trades, 10 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $IBP stock by insiders over the last 6 months:
- JEFFREY W. EDWARDS (President, CEO and Chairman) sold 400,000 shares for an estimated $125,624,000
- JANET E. JACKSON sold 1,410 shares for an estimated $413,567
- MICHAEL THOMAS MILLER (Executive VP & CFO) has made 10 purchases buying 990 shares for an estimated $198,609 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IBP Hedge Fund Activity
We have seen 217 institutional investors add shares of $IBP stock to their portfolio, and 232 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 353,009 shares (-82.0%) from their portfolio in Q4 2025, for an estimated $91,567,004
- NEUBERGER BERMAN GROUP LLC removed 255,939 shares (-50.1%) from their portfolio in Q1 2026, for an estimated $67,862,225
- BAMCO INC /NY/ removed 224,966 shares (-53.2%) from their portfolio in Q1 2026, for an estimated $59,649,734
- WESTFIELD CAPITAL MANAGEMENT CO LP added 208,248 shares (+inf%) to their portfolio in Q1 2026, for an estimated $55,216,957
- BLACKROCK, INC. added 137,998 shares (+3.8%) to their portfolio in Q1 2026, for an estimated $36,590,169
- MORGAN STANLEY removed 125,962 shares (-16.2%) from their portfolio in Q1 2026, for an estimated $33,398,824
- JANE STREET GROUP, LLC added 123,860 shares (+596.4%) to their portfolio in Q1 2026, for an estimated $32,841,478
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$IBP Revenue
$IBP had revenues of $660.5M in Q1 2026. This is a decrease of -3.55% from the same period in the prior year.
You can track IBP financials on Quiver Quantitative's IBP stock page.
You can access data on IBP stock through the Quiver Quantitative API.
$IBP Congressional Stock Trading
Members of Congress have traded $IBP stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $IBP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 6 times. They made 3 purchases worth up to $45,000 on 03/24, 03/12, 01/29 and 3 sales worth up to $45,000 on 02/26, 01/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$IBP Price Targets
Multiple analysts have issued price targets for $IBP recently. We have seen 8 analysts offer price targets for $IBP in the last 6 months, with a median target of $234.0.
Here are some recent targets:
- Kurt Yinger from DA Davidson set a target price of $242.0 on 06/01/2026
- Michael Rehaut from JP Morgan set a target price of $195.0 on 05/13/2026
- Keith Hughes from Truist Securities set a target price of $200.0 on 05/11/2026
- Sam Reid from Wells Fargo set a target price of $250.0 on 05/08/2026
- Stephen Kim from Evercore ISI Group set a target price of $226.0 on 05/08/2026
- Trey Grooms from Stephens & Co. set a target price of $240.0 on 05/08/2026
- Mike Dahl from RBC Capital set a target price of $228.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
